Corcept, Optime move to dismiss parts of Teva's amended US antitrust complaint
MLex Summary: Corcept Therapeutics and Optime Care asked a US judge to dismiss monopolization claims from Teva Pharmaceuticals. In a joint partial motion to dismiss the second amended complaint, Corcept and...To view the full article, register now.
Already a subscriber? Click here to view full article